Skip to main content

Advertisement

Table 5 Disorder-level score allocation criteria for the seven individual severity metrics contributing to overall severity score. Sub-scores assigned at disorder-level, based on analysis of group data obtained via structured review of electronic health records from 250 affected dogs per disorder during 2013

From: Health-related welfare prioritisation of canine disorders using electronic health records in primary care practice in the UK

Disorder-level sub-score category Severity metric 1: Disorder as reason presented for veterinary care during year Severity metric 2: Frequency of disorder-related primary care clinic visits during year Severity metric 3: Chronicity of disorder-related analgesia (including AI) therapy during year Severity metric 4: Range of other (non-analgesic/AI) therapeutic groups used for disorder treatment/management in year Severity metric 5: Surgical depth of any disorder-related procedures performed under GA/sedation during year Severity metric 6: Disorder-related overnight primary-care hospitalisations during year Severity metric 7: Disorder-related referral during year
Aims to reflect: Owner perception of need/urgency of need for veterinary care Veterinary opinion/owner perceived importance for repeated veterinary visits Vet/owner perceived need for any pain relief and for how long (i.e. over shorter or longer periods of time) Clinical indications and perception of extent of veterinary intervention required to manage the disorder The level/depth of surgical intervention required to manage the disorder appropriately Vet/owner perceived requirement for veterinary in-patient level care related to the disorder Vet/owner perceived requirement for referral-level care related to the disorder
Assigned based on assessment of group data showing: Evidence for the disorder as a primary or secondary/partial presenting complaint, or an incidental finding Median number of disorder-related EHR visit entries per case in the year Proportion of cases prescribed disorder-related analgesic drug therapy, for up to 14 days or longer Proportion of cases prescribed/sold no, 1–2, or > 2 different non-analgesic/non-AI therapeutic groups related to the disorder Proportion of cases within different maximum disorder-related surgical intervention categories Median number of disorder-related overnight primary-care hospitalisations per case during the year Proportion of cases with evidence for at least one disorder-related referral during the year.
Sub-score 0 N/A (At least one disorder-related visit during year required for selection as case) N/A (At least one disorder-related visit during year required for selection as case) 0 cases prescribed disorder-related analgesia/AIs during year 0 cases were sold disorder-related, non-analgesic/AI therapeutic interventions No procedures: 0 cases underwent disorder-related procedures under GA or sedation 0 cases with disorder-related overnight hospitalisation at a primary care clinic 0 cases referred for investigation/management/treatment of the disorder
Sub-score 1 Disorder only ever noted as an incidental finding in > 50% of cases Median 1–2 disorder-related visits per case < 50% cases prescribed some form of analgesia / AI therapy for the disorder Under 50% (but > 0%) of cases were sold ANY disorder-related, non-analgesic/AI therapeutic interventions Few procedures: Under 50% (but > 0%) of cases underwent disorder-related procedures under GA or sedation At least 1 case with an overnight hospitalisation but median overnight disorder-related hospitalisations per case: 0 Up to 1% of study cases referred for investigation/management/treatment of the disorder
Sub-score 2 > 50% of cases presented with disorder as a partial presenting complaint, at most Median 3–5 disorder-related visits per case 50% or more cases prescribed 1–14 consecutive days of analgesia / AI therapy for the disorder > 50% of cases were sold disorder-related, non-analgesic/AI interventions from 1 or 2 distinct therapeutic groups Many minor procedures: 50% or more cases underwent procedures no deeper than skin/CT/MM under GA or sedation Median disorder-related overnight hospitalisations per case during study year: 1 to 5 1–3% of study cases referred for investigation/management/treatment of the disorder
Sub-score 3 > 50% of cases presented at least once with disorder as primary complaint Median > 5 disorder-related visits per case > 50% of cases prescribed > 14 consecutive days analgesia / AI therapy for the disorder >  50% of cases were sold disorder-related, non-analgesic/AI interventions from > 2 distinct therapeutic groups Many major procedures: > 50% cases underwent procedures deeper than skin/CT/MM under GA or sedation Median disorder-related overnight hospitalisations per case: > 5 > 3% of study cases referred for investigation/management/treatment of the disorder
If no single relevant results category contains > 50% of dogs…… If % of dogs in categories 1 and 2 (above) combined exceeds % in categories 2 and 3 combined: Assign sub-score 2 If % of dogs in categories 2 and 3 combined exceeds % in categories 1 and 2 combined: Assign sub-score 3 N/A If % of dogs in categories 1 and 2 (above) combined exceeds % in categories 2 and 3 combined: Assign sub-score 2 If % of dogs in categories 2 and 3 combined exceeds % in categories 1 and 2 combined: Assign sub-score 3 N/A If % of dogs in categories 1 and 2 (above) combined exceeds % in categories 2 and 3 combined: Assign sub-score 2 If % of dogs in categories 2 and 3 combined exceeds % in categories 1 and 2 combined: Assign sub-score 3 N/A N/A
  1. Abbreviations: AI Anti-inflammatory, GA General anaesthesia, CT Connective tissue, MM Mucous membrane, N/A Not applicable